Cell Harvester Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Displacement Collector, Therapy Collector), By Application (Cell Proliferation Assays, Mixed Lymphocyte Culture (MLC) Assays, Receptor-Binding Assays, Single-Stranded Template DNA Harvesting, Others), By Region and Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 3.78 Billion
CAGR (2026-2031)	6.61%
Fastest Growing Segment	Displacement Collector
Largest Market	North America
Market Size (2031)	USD 5.55 Billion

Market Overview

The Global Cell Harvester Market is projected to grow from USD 3.78 Billion in 2025 to USD 5.55 Billion by 2031 at a 6.61% CAGR. Cell harvesters are essential devices designed to efficiently isolate, collect, and prepare cells from biological sources for diverse applications in research and therapeutics. The market's expansion is fundamentally driven by the escalating demand from regenerative medicine, the growth of the biopharmaceutical industry, and the increasing adoption of cell-based therapies for chronic and infectious diseases. Advancements in automation and closed-system technologies also contribute significantly by enhancing efficiency and precision in cell processing. According to the Biotechnology Innovation Organization (BIO), the broader bioscience product market was projected to be $1.7 trillion in 2025, underscoring the substantial underlying industry supporting cell harvesting technologies.

However, a significant challenge impeding market expansion is the high cost associated with advanced cell harvesting devices and their supporting procedures. This includes the capital investment for sophisticated automated systems and the operational expenses for specialized consumables and skilled personnel.

Key Market Drivers

The expansion of regenerative medicine and cell therapies significantly propels the Global Cell Harvester Market. These innovative therapeutic approaches, which involve isolating and processing specific cells for disease treatment, directly depend on efficient cell harvesting technologies. As more cell and gene therapies advance through clinical development and regulatory approval, the demand for reliable and scalable cell processing solutions intensifies. Cell harvesters play a crucial role in preparing cells for infusion or transplantation, ensuring high viability and purity. As of January 2026, 438 cell and gene therapies were in development in the United States, according to PhRMA, highlighting the substantial pipeline requiring advanced processing capabilities.

Advancements in automation and single-use technologies also substantially influence the cell harvester market. Automated systems reduce manual labor, enhance reproducibility, and minimize contamination risks, which are critical in sensitive cell therapy manufacturing. The integration of single-use components, such as disposable bags and tubing sets, further simplifies operations, decreases turnaround times, and lowers the risk of cross-contamination by eliminating extensive cleaning and sterilization. According to European Biotechnology Magazine in February 2026, Sartorius invested EUR 442 million in 2025, including in the expansion of bioprocess production in Europe and Asia. This focus on advanced bioprocessing directly benefits cell harvesting applications. Furthermore, according to Biocom, in March 2026, the total deal value across the life science sector reached $372 billion in 2025, demonstrating the broader industry growth that underpins demand for cell harvesting innovation.

Download Free Sample Report

Key Market Challenges

The high cost of advanced cell harvesting devices and their associated supporting procedures presents a significant impediment to the expansion of the Global Cell Harvester Market. This includes the substantial capital investment required for acquiring automated systems necessary for efficient cell isolation and collection. Furthermore, ongoing operational expenses for specialized consumables, reagents, and the skilled personnel needed to operate and maintain these technologies add considerably to the overall cost burden for end-users. These financial demands limit broader adoption, particularly among smaller research institutions, emerging biopharmaceutical companies, and academic laboratories with restrictive budgets.

The substantial investment required in the broader regenerative medicine sector underscores the financial scale involved in advanced therapies, which directly impacts the adoption of specialized equipment like cell harvesters. According to the Alliance for Regenerative Medicine, in 2025, the regenerative medicine sector secured $11.1 billion in funding across 216 financings. The elevated costs of cell harvesting technology directly contribute to the significant financial outlay needed to establish and operate cell therapy manufacturing and research facilities, thereby restraining market growth as organizations weigh the substantial initial capital expenditure against potential returns and operational budgets.

Key Market Trends

The expanding pipeline of cell and gene therapies is generating an intensified requirement for high-throughput processing within the Global Cell Harvester Market. This trend emphasizes the capacity to manage a greater volume of samples and cell populations concurrently, significantly accelerating research, development, and ultimately commercial production cycles. High-throughput cell harvesting systems enable streamlined workflows, critical for efficient scale-up and ensuring consistency across large batches. For instance, according to News on Projects in February 2026, Cytiva established a 30,000 square foot bioprocessing facility in Bengaluru, India, specifically designed to accelerate drug development for biopharma companies by facilitating scaled operations.

Concurrently, the integration of artificial intelligence and digital monitoring is transforming cell harvesting by enhancing precision and operational efficiency. AI algorithms and advanced digital tools provide capabilities for real-time analysis of cell health, growth parameters, and optimal harvesting conditions, moving beyond traditional manual observations. These technologies minimize human error, predict potential process deviations, and optimize yield and viability, thereby improving the overall quality and reproducibility of harvested cells. As reported by Emory University in December 2025, neuroscientists installed a $1.5 million automated cell culture system capable of monitoring and analyzing 20,000 organoids simultaneously using AI to determine cell differentiation patterns.

Segmental Insights

The Displacement Collector segment is experiencing rapid growth within the Global Cell Harvester Market, primarily driven by its inherent operational efficiency and superior cell recovery rates. These systems are highly valued for their ability to gently and efficiently separate cells from culture media, critically maintaining cell integrity and viability. This capability is essential for various high-demand applications, including stem cell therapy, regenerative medicine, and monoclonal antibody production, where the functional integrity of harvested cells is paramount. Consequently, the segment's reliability and effectiveness across diverse biomedical applications contribute significantly to its expanding adoption in both research and clinical workflows.

Regional Insights

North America dominates the global cell harvester market due to its advanced biopharmaceutical infrastructure, featuring prominent biotech companies, leading hospitals, and academic institutions that consistently drive demand for sophisticated technologies. Significant investments in cell-based research and development initiatives further propel market expansion across the region. A robust regulatory environment, overseen by bodies such as the U.S. Food and Drug Administration's Center for Biologics Evaluation and Research (CBER), facilitates innovation and ensures adherence to quality standards for cellular and tissue-based therapies. This supportive ecosystem, coupled with a strong emphasis on personalized medicine and regenerative therapies, fosters the adoption of efficient and scalable cell processing solutions, cementing North America's leading position.

Recent Developments

• In January 2026, I&L Biosystems collaborated with GEA to expand the distribution of the GEA kytero® 10 in the Benelux region. This partnership focused on the sale, installation, and maintenance of GEA's tabletop single-use disk-stack centrifuge, a device specifically engineered for efficient and gentle cell harvesting. The kytero® 10 is designed for research and small-scale production environments, accommodating bioreactors from 1 to 10 liters. This product launch and collaboration directly supports advancements in the Global Cell Harvester Market by offering a compact, single-use solution that enhances cell recovery and viability while requiring minimal operational space.
• In October 2025, Cellipont Bioservices, a contract development and manufacturing organization, partnered with Ernexa Therapeutics to advance Ernexa's lead cell therapy, ERNA-101, towards clinical trials for ovarian cancer. This collaboration is particularly noteworthy for the Global Cell Harvester Market as Ernexa's innovative allogeneic synthetic induced mesenchymal stem cells (iMSCs) offer a scalable, off-the-shelf treatment. This approach eliminates the necessity for patient-specific cell harvesting, a key step in traditional cell therapies, and potentially broadens access to care by reducing manufacturing complexities and treatment timelines.
• In September 2025, Cellular Agriculture announced the expansion into a new research and development facility, along with plans for a pilot-scale launch in Q1 2026. The new facility, located at Corsham Science Park, was specifically designed to accelerate the scaling of cultivated food technologies. A significant feature of this facility is its integration of advanced automation and in-situ harvesting capabilities, aimed at bridging the gap between laboratory breakthroughs and industrial production. This focus on "in-situ harvesting" represents a direct innovation within the Global Cell Harvester Market, enhancing efficiency and de-risking scale-up for cellular agriculture applications.
• In April 2025, Nikon CeLL innovation Co., Ltd. (NCLi) formed a strategic licensing agreement with RoosterBio, Inc., a leading stem cell technology company. This collaboration aimed to provide an integrated solution for the development and manufacturing of human mesenchymal stem cell (MSC) and extracellular vesicle (EV) therapeutics in Japan. Through this partnership, NCLi enhanced its capabilities to include critical stages such as cell expansion, harvest, formulation, and cryopreservation of MSCs in both 2D flasks and 3D bioreactors. This agreement significantly impacts the Global Cell Harvester Market by streamlining the overall cell manufacturing workflow for advanced therapies.

Key Market Players

• Human Med AG
• ADS Biotec Inc.
• PerkinElmer Inc.
• TERUMO BCT, INC.
• Esco Micro Pte. Ltd.
• Gasser Apparatebau und Laborzubehör
• Sartorius AG
• Cox Scientific Ltd.
• Pall Corporation

By Type	By Application	By Region
Displacement Collector Therapy Collector	Cell Proliferation Assays Mixed Lymphocyte Culture (MLC) Assays Receptor-Binding Assays Single-Stranded Template DNA Harvesting Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Cell Harvester Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Cell Harvester Market, By Type:

• Displacement Collector
• Therapy Collector

• Cell Harvester Market, By Application:

• Cell Proliferation Assays
• Mixed Lymphocyte Culture (MLC) Assays
• Receptor-Binding Assays
• Single-Stranded Template DNA Harvesting
• Others

• Cell Harvester Market, By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE